Latest Breaking News On - Eukles asset management - Page 9 : comparemela.com

Eukles Asset Management reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,180 shares of the specialty pharmaceutical company’s stock after selling 144 shares during the quarter. Eukles Asset Management’s holdings […]

New zealand generalNew zealandUnited statesRobertw bairdPhilipl johnsonPatricia carrRoyal bankJazz pharmaceuticalsNeedham companySecurities exchange commissionExchange commissionWellington management groupJazz pharmaceuticals price performanceQuarter for jazz pharmaceuticalsVanguard group incNews ratings for jazz pharmaceuticals daily